Court, Explained
U.S. Federal District Courts
Back to docket
N.D. Cal.Procedural orderFiled Feb. 5, 2020

Illumina, Inc. v. BGI Genomics Co., Ltd

Judge
William Orrick
Docket
3:19-cv-03770
Court
U.S. District Court · Northern District of California
Pages
12
Intellectual PropertyCivil ProcedureMotion to Dismiss
In one sentence

In Illumina v. BGI Genomics, Judge Orrick struck several defenses and partly granted Illumina’s dismissal motion, dismissing willful-infringement claims but allowing induced-infringement claims.

Who this affects

Illumina and its affiliate Illumina Cambridge obtained rulings striking CGI’s affirmative defenses and dismissing CGI’s willful-infringement counterclaim. CGI’s induced-infringement counterclaim and its ability to amend six affirmative defenses remained in the case.

What happened

In Illumina, Inc. v. BGI Genomics Co., Ltd., the defendants, collectively called CGI, asserted defenses and a counterclaim accusing Illumina of infringing CGI’s patent. CGI claimed Illumina’s lawyers and expert misled patent decision-makers about prior-art references and asserted several other defenses.

The court struck CGI’s inequitable-conduct and unclean-hands defenses without leave to amend, finding that the allegations described attorney arguments about prior art rather than demonstrably false statements and did not adequately allege intent to deceive. It also struck six other defenses—prosecution laches, prosecution-history estoppel, statute of limitations, a patent-marking defense, no enhanced damages, and no exceptional case—with leave to amend. The court dismissed CGI’s willful-infringement counterclaim but allowed its induced-infringement counterclaim to proceed.

Judge William H. Orrick ruled that CGI had not adequately alleged that Illumina knew of the patent before the lawsuit for purposes of willful infringement. He found the allegations that Illumina encouraged customers to infringe through materials and software sufficient for induced infringement, including alleged knowledge after the counterclaim was served. The order granted Illumina’s motion to strike and granted in part and denied in part its motion to dismiss.

The detailed version

For law students, journalists, and other readers who want the full reasoning

Case
Illumina, Inc. v. BGI Genomics Co., Ltd · No. 3:19-cv-03770
Judge
William Orrick
Date
Feb. 5, 2020

Background

Illumina, Inc. and Illumina Cambridge Ltd. sued BGI Genomics Co., Ltd., BGI Americas Corp., MGI Tech. Co., Ltd., MGI Americas, Inc., and Complete Genomics Inc. The opinion collectively refers to the defendants as CGI. CGI filed an answer asserting twelve affirmative defenses and a counterclaim alleging infringement of one of CGI’s patents.

Illumina moved under Federal Rule of Civil Procedure 12(f) to strike CGI’s Third, Fourth, Sixth, Seventh, Ninth, Tenth, Eleventh, and Twelfth affirmative defenses. It also moved under Rule 12(b)(6), which permits dismissal for failure to state a legally sufficient claim, to dismiss CGI’s counterclaims for induced infringement and willful infringement and the related request for damages.

Motion to Strike

CGI’s Eleventh affirmative defense alleged inequitable conduct. CGI claimed that Illumina’s attorneys and expert made false or misleading statements about several prior-art references during earlier proceedings before the Patent Trial and Appeal Board and the Federal Circuit. The alleged subjects included the meanings of “efficiency” and “yield,” the characteristics of an “Azidomethyl” group, the description of the “Boyer” reference and the behavior of the “AZT” molecule, and whether certain molecules would degrade DNA strands.

The court explained that inequitable conduct requires particularized allegations that a person involved in patent prosecution made a material misrepresentation or omission and did so with a specific intent to deceive the patent authorities. The court concluded that CGI’s allegations, viewed favorably to CGI, described attorney interpretations and arguments about prior art rather than demonstrably false factual statements. The prior-art references were available to the decision-makers and opposing parties, and the earlier decisions independently addressed the disputed issues. The court also found that CGI did not adequately identify which individuals made the alleged misrepresentations or plead facts supporting knowledge and a specific intent to deceive.

The court therefore struck CGI’s Eleventh affirmative defense of inequitable conduct without leave to amend. It also struck CGI’s Twelfth affirmative defense of unclean hands without leave to amend because it was based on the same conduct.

Illumina’s motion also challenged CGI’s Third, Fourth, Sixth, Seventh, Ninth, and Tenth affirmative defenses. The court applied the requirement that an affirmative defense include factual support rather than merely a conclusory label. It found that CGI’s Third, Sixth, Ninth, and Tenth defenses lacked adequate factual support, and it found that the Ninth and Tenth defenses were not proper affirmative defenses because they addressed Illumina’s burden to prove enhanced damages or an exceptional case.

The court granted Illumina’s motion to strike CGI’s Third, Fourth, Sixth, Seventh, Ninth, and Tenth affirmative defenses with leave to amend. The order states that any amended pleading had to be filed within 20 days of the order.

Motion to Dismiss

The court dismissed CGI’s willful-infringement counterclaim. It held that CGI had not adequately alleged that Illumina knew of the patent at the relevant time before the lawsuit. Allegations that Illumina routinely monitored intellectual-property developments were not enough, and alleged knowledge obtained after the lawsuit began was not relevant to the willful-infringement claim.

The court allowed CGI’s induced-infringement counterclaim to proceed. CGI alleged that Illumina provided customers with marketing materials, user guides, technical literature, and bioinformatics software applications that encouraged infringing use. Although the court found CGI’s allegations of pre-suit knowledge insufficient, it held that CGI could rely on alleged post-suit knowledge for induced infringement. The court found CGI’s allegation that Illumina learned of the patent when it was served with the counterclaim sufficient at the pleading stage.

Disposition

Judge William H. Orrick granted Illumina’s motion to strike CGI’s Eleventh and Twelfth affirmative defenses without leave to amend. He granted Illumina’s motion to strike CGI’s Third, Fourth, Sixth, Seventh, Ninth, and Tenth affirmative defenses with leave to amend. He granted in part and denied in part Illumina’s motion to dismiss: the willful-infringement counterclaim was dismissed, while the induced-infringement counterclaim was allowed to proceed.

The authoritative version

Read the full 12-page opinion on CourtListener, the free public archive maintained by the Free Law Project.

Open opinion PDF →
Summary written with AI assistance. See how summaries are made. Spot something wrong? Tell us.